IPH6501

· Innate Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IPH6501, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]